Oliver F. Bathe

Closest collaborators

The 25 strongest of 47 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Grainne Mary O'Kane · 7 shared papers, 2021–2025 · strength 0.92
   • Paper Multi-omics whole-genome characterization of the copy number landscape of metastatic pancreatic ductal adenocarcinoma. DOI 10.1016/j.isci.2025.113176↗
   • Paper The tandem duplicator phenotype may be a novel targetable subgroup in pancreatic cancer. DOI 10.1038/s41698-025-00888-8↗
   • Paper Clinically impactful metabolic subtypes of pancreatic ductal adenocarcinoma (PDAC). DOI 10.3389/fgene.2023.1282824↗
2. Steve Gallinger · 7 shared papers, 2021–2025 · strength 0.92
   • Paper Multi-omics whole-genome characterization of the copy number landscape of metastatic pancreatic ductal adenocarcinoma. DOI 10.1016/j.isci.2025.113176↗
   • Paper The tandem duplicator phenotype may be a novel targetable subgroup in pancreatic cancer. DOI 10.1038/s41698-025-00888-8↗
   • Paper Clinically impactful metabolic subtypes of pancreatic ductal adenocarcinoma (PDAC). DOI 10.3389/fgene.2023.1282824↗
3. Joanna M. Karasinska · 6 shared papers, 2021–2025 · strength 0.80
   • Paper Multi-omics whole-genome characterization of the copy number landscape of metastatic pancreatic ductal adenocarcinoma. DOI 10.1016/j.isci.2025.113176↗
   • Paper The tandem duplicator phenotype may be a novel targetable subgroup in pancreatic cancer. DOI 10.1038/s41698-025-00888-8↗
   • Paper Clinically impactful metabolic subtypes of pancreatic ductal adenocarcinoma (PDAC). DOI 10.3389/fgene.2023.1282824↗
4. David F. Schaeffer · 6 shared papers, 2021–2025 · strength 0.80
   • Paper Multi-omics whole-genome characterization of the copy number landscape of metastatic pancreatic ductal adenocarcinoma. DOI 10.1016/j.isci.2025.113176↗
   • Paper The tandem duplicator phenotype may be a novel targetable subgroup in pancreatic cancer. DOI 10.1038/s41698-025-00888-8↗
   • Paper Clinically impactful metabolic subtypes of pancreatic ductal adenocarcinoma (PDAC). DOI 10.3389/fgene.2023.1282824↗
5. Daniel John Renouf · 6 shared papers, 2021–2025 · strength 0.80
   • Paper Multi-omics whole-genome characterization of the copy number landscape of metastatic pancreatic ductal adenocarcinoma. DOI 10.1016/j.isci.2025.113176↗
   • Paper The tandem duplicator phenotype may be a novel targetable subgroup in pancreatic cancer. DOI 10.1038/s41698-025-00888-8↗
   • Paper Clinically impactful metabolic subtypes of pancreatic ductal adenocarcinoma (PDAC). DOI 10.3389/fgene.2023.1282824↗
6. Jennifer Jane Knox · 6 shared papers, 2021–2025 · strength 0.76
   • Paper Multi-omics whole-genome characterization of the copy number landscape of metastatic pancreatic ductal adenocarcinoma. DOI 10.1016/j.isci.2025.113176↗
   • Paper The tandem duplicator phenotype may be a novel targetable subgroup in pancreatic cancer. DOI 10.1038/s41698-025-00888-8↗
   • Paper Prognostic value of early changes in CT-measured body composition in patients receiving chemotherapy for unresectable p… DOI 10.1007/s00330-021-07899-6↗
7. Janessa J. Laskin · 5 shared papers, 2021–2025 · strength 0.64
   • Paper Multi-omics whole-genome characterization of the copy number landscape of metastatic pancreatic ductal adenocarcinoma. DOI 10.1016/j.isci.2025.113176↗
   • Paper The tandem duplicator phenotype may be a novel targetable subgroup in pancreatic cancer. DOI 10.1038/s41698-025-00888-8↗
   • Paper Integrative analysis of KRAS wildtype metastatic pancreatic ductal adenocarcinoma reveals mutation and expression-based… DOI 10.1038/s41467-022-33718-7↗
8. Rachel Anne Goodwin · 5 shared papers, 2021–2025 · strength 0.64
   • Paper Multi-omics whole-genome characterization of the copy number landscape of metastatic pancreatic ductal adenocarcinoma. DOI 10.1016/j.isci.2025.113176↗
   • Paper The tandem duplicator phenotype may be a novel targetable subgroup in pancreatic cancer. DOI 10.1038/s41698-025-00888-8↗
   • Paper Integrative analysis of KRAS wildtype metastatic pancreatic ductal adenocarcinoma reveals mutation and expression-based… DOI 10.1038/s41467-022-33718-7↗
9. James Thomas Topham · 5 shared papers, 2021–2025 · strength 0.64
   • Paper Multi-omics whole-genome characterization of the copy number landscape of metastatic pancreatic ductal adenocarcinoma. DOI 10.1016/j.isci.2025.113176↗
   • Paper The tandem duplicator phenotype may be a novel targetable subgroup in pancreatic cancer. DOI 10.1038/s41698-025-00888-8↗
   • Paper Integrative analysis of KRAS wildtype metastatic pancreatic ductal adenocarcinoma reveals mutation and expression-based… DOI 10.1038/s41467-022-33718-7↗
10. Faiyaz Notta · 5 shared papers, 2021–2025 · strength 0.64
    • Paper Multi-omics whole-genome characterization of the copy number landscape of metastatic pancreatic ductal adenocarcinoma. DOI 10.1016/j.isci.2025.113176↗
    • Paper The tandem duplicator phenotype may be a novel targetable subgroup in pancreatic cancer. DOI 10.1038/s41698-025-00888-8↗
    • Paper Integrative analysis of KRAS wildtype metastatic pancreatic ductal adenocarcinoma reveals mutation and expression-based… DOI 10.1038/s41467-022-33718-7↗
11. Steve E. Kalloger · 4 shared papers, 2021–2025 · strength 0.47
    • Paper Multi-omics whole-genome characterization of the copy number landscape of metastatic pancreatic ductal adenocarcinoma. DOI 10.1016/j.isci.2025.113176↗
    • Paper Integrative analysis of KRAS wildtype metastatic pancreatic ductal adenocarcinoma reveals mutation and expression-based… DOI 10.1038/s41467-022-33718-7↗
    • Paper Delving into Early-onset Pancreatic Ductal Adenocarcinoma: How Does Age Fit In? DOI 10.1158/1078-0432.ccr-20-1042↗
12. Erica S. Tsang · 4 shared papers, 2021–2025 · strength 0.46
    • Paper The tandem duplicator phenotype may be a novel targetable subgroup in pancreatic cancer. DOI 10.1038/s41698-025-00888-8↗
    • Paper Integrative analysis of KRAS wildtype metastatic pancreatic ductal adenocarcinoma reveals mutation and expression-based… DOI 10.1038/s41467-022-33718-7↗
    • Paper Delving into Early-onset Pancreatic Ductal Adenocarcinoma: How Does Age Fit In? DOI 10.1158/1078-0432.ccr-20-1042↗
13. Daniel W. Chan · 2 shared papers, 2022–2024 · strength 0.35
    • Paper Detection of Pancreatic Ductal Adenocarcinoma-Associated Proteins in Serum. DOI 10.1016/j.mcpro.2023.100687↗
    • Paper Neoplastic cell enrichment of tumor tissues using coring and laser microdissection for proteomic and genomic analyses o… DOI 10.1186/s12014-022-09373-x↗
14. Hui Zhang · 2 shared papers, 2022–2024 · strength 0.35
    • Paper Detection of Pancreatic Ductal Adenocarcinoma-Associated Proteins in Serum. DOI 10.1016/j.mcpro.2023.100687↗
    • Paper Neoplastic cell enrichment of tumor tissues using coring and laser microdissection for proteomic and genomic analyses o… DOI 10.1186/s12014-022-09373-x↗
15. Ralph H. Hruban MD · 2 shared papers, 2022–2024 · strength 0.35
    • Paper Detection of Pancreatic Ductal Adenocarcinoma-Associated Proteins in Serum. DOI 10.1016/j.mcpro.2023.100687↗
    • Paper Neoplastic cell enrichment of tumor tissues using coring and laser microdissection for proteomic and genomic analyses o… DOI 10.1186/s12014-022-09373-x↗
16. George Zogopoulos · 2 shared papers, 2023–2025 · strength 0.33
    • Paper The tandem duplicator phenotype may be a novel targetable subgroup in pancreatic cancer. DOI 10.1038/s41698-025-00888-8↗
    • Paper Clinically impactful metabolic subtypes of pancreatic ductal adenocarcinoma (PDAC). DOI 10.3389/fgene.2023.1282824↗
17. Qing Kay Li · 2 shared papers, 2022–2024 · strength 0.30
    • Paper Frozen tissue coring and layered histological analysis improves cell type-specific proteogenomic characterization of pa… DOI 10.1186/s12014-024-09450-3↗
    • Paper Neoplastic cell enrichment of tumor tissues using coring and laser microdissection for proteomic and genomic analyses o… DOI 10.1186/s12014-022-09373-x↗
18. Bing Zhang · 2 shared papers, 2022–2024 · strength 0.30
    • Paper Frozen tissue coring and layered histological analysis improves cell type-specific proteogenomic characterization of pa… DOI 10.1186/s12014-024-09450-3↗
    • Paper Neoplastic cell enrichment of tumor tissues using coring and laser microdissection for proteomic and genomic analyses o… DOI 10.1186/s12014-022-09373-x↗
19. Hassan A. Ali · 2 shared papers, 2022–2025 · strength 0.28
    • Paper Multi-omics whole-genome characterization of the copy number landscape of metastatic pancreatic ductal adenocarcinoma. DOI 10.1016/j.isci.2025.113176↗
    • Paper Integrative analysis of KRAS wildtype metastatic pancreatic ductal adenocarcinoma reveals mutation and expression-based… DOI 10.1038/s41467-022-33718-7↗
20. Liwei Cao · 1 shared paper, 2024 · strength 0.23
    • Paper Detection of Pancreatic Ductal Adenocarcinoma-Associated Proteins in Serum. DOI 10.1016/j.mcpro.2023.100687↗
21. T. Mamie Lih · 1 shared paper, 2024 · strength 0.23
    • Paper Detection of Pancreatic Ductal Adenocarcinoma-Associated Proteins in Serum. DOI 10.1016/j.mcpro.2023.100687↗
22. Hui‐Li Wong · 2 shared papers, 2021–2022 · strength 0.20
    • Paper Integrative analysis of KRAS wildtype metastatic pancreatic ductal adenocarcinoma reveals mutation and expression-based… DOI 10.1038/s41467-022-33718-7↗
    • Paper Subtype-Discordant Pancreatic Ductal Adenocarcinoma Tumors Show Intermediate Clinical and Molecular Characteristics. DOI 10.1158/1078-0432.ccr-20-2831↗
23. Michael K.C. Lee · 2 shared papers, 2021 · strength 0.19
    • Paper Delving into Early-onset Pancreatic Ductal Adenocarcinoma: How Does Age Fit In? DOI 10.1158/1078-0432.ccr-20-1042↗
    • Paper Subtype-Discordant Pancreatic Ductal Adenocarcinoma Tumors Show Intermediate Clinical and Molecular Characteristics. DOI 10.1158/1078-0432.ccr-20-2831↗
24. Yuefan Wang · 1 shared paper, 2024 · strength 0.18
    • Paper Frozen tissue coring and layered histological analysis improves cell type-specific proteogenomic characterization of pa… DOI 10.1186/s12014-024-09450-3↗
25. Sara R. Savage · 1 shared paper, 2024 · strength 0.18
    • Paper Frozen tissue coring and layered histological analysis improves cell type-specific proteogenomic characterization of pa… DOI 10.1186/s12014-024-09450-3↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.